Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:21:24 2024-05-13 pm EDT			5-day change	1st Jan Change
0.0055 ^USD	-72.50%		-72.50%	-95.26%

Mar. 06	Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

H-CYTE Inc. Appoints Andre Terzic to Board of Directors

July 29, 2019 at 08:00 am EDT

H-CYTE Inc. announced that it has appointed Andre Terzic, M.D., Ph.D., to its Board of Directors. Dr. Andre Terzic is the Michael & Mary Sue Shannon Director, Mayo Clinic Center for Regenerative Medicine, Marriott Family Professor of Cardiovascular Diseases Research and Professor of Medicine and Pharmacology. A pioneer in cardiovascular regenerative medicine, Dr. Terzic has dedicated his career to next-generation diagnostic and therapeutic solutions. His research includes over 450 articles. Dr. Terzic brings a wealth of expertise in science and strategy across the regenerative medicine space to help guide H-CYTE’s vision in the years to come.

Latest news about Innoveren Scientific Inc.

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	Mar. 06	CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 15	CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	23-07-10	CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	23-07-10	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-10	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	23-05-09	CI
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	23-04-11	CI
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	23-02-23	CI
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	22-12-28	CI
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
H-CYTE, Inc. announced that it has received $0.225 million in funding	22-09-28	CI
H-CYTE, Inc. (OTCQB: HCYT) entered into a letter of intent to acquire SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown for $2.3 million.	22-09-18	CI
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc.	22-09-07	CI
H-CYTE, Inc. acquired Jantibody, LLC.	22-09-07	CI
H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
H-Cyte, Inc. Closes Its Clinic in Scottsdale, Arizona	22-06-09	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
H-CYTE, Inc. Moves its Headquarters	22-04-04	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	22-02-24	CI
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors	22-01-14	CI
H-CYTE, Inc. entered into a letter of intent to acquire Catheter Precision, Inc.	22-01-10	CI
H-CYTE, Inc. Announces Resignation of Tanya Rhodes as Interim Chief Executive Officer	21-12-07	CI

Chart Innoveren Scientific Inc.

Duration

Period

More charts

Company Profile

Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INNOVEREN SCIENTIFIC INC.	-95.26%	29.36K
THERMO FISHER SCIENTIFIC	+12.85%	229B
DANAHER CORPORATION	+13.88%	195B
INTUITIVE SURGICAL, INC.	+18.39%	142B
BOSTON SCIENTIFIC CORPORATION	+28.78%	109B
SIEMENS HEALTHINEERS AG	+1.41%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+18.24%	54.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	52.09B
AGILENT TECHNOLOGIES, INC.	+10.83%	45.15B
GE HEALTHCARE TECHNOLOGIES INC.	+5.94%	37.39B

Other Advanced Medical Equipment & Technology